RxDoctor Payments Data

Gabriel Urrea-Botero, MD

Geriatric Medicine · San Antonio, TXNPI 1285887166

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,085 of the $3,297 with a category attached, or 63.3%. Medtronic accounts for 80.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,679 and has fallen 96.2% since, to $101 in 2025. Among geriatric medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,297in general payments, 2019–2025

Across 29 payments — averaging $113.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Smith+Nephew$179
  • Urgo Medical North America, LLC$164
  • AstraZeneca$125
  • Novo Nordisk$125
  • Hydrofera LLC$29
  • plus $28 from 2 others

What the payments were for

  • Travel & lodging$2,08563%
  • Food & beverage$1,21137%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)11$2,647
Smith+Nephew9$179
Urgo Medical North America, LLC4$164
AstraZeneca1$125
Novo Nordisk1$125
Hydrofera LLC1$29
Radius Health, Inc.1$14
Amgen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,297 in reported general payments places this provider in the 90th percentile of 275 geriatric medicine providers in Texas.

See all geriatric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$6,571
Medicare patients
18
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast19$106,169
XareltoRivaroxaban18$12,213
Calcitriol14$4,486
Doxycycline Hyclate93$2,246
Triamcinolone Acetonide84$1,241
Clobetasol Propionate14$1,179
Gabapentin24$866
Gentamicin Sulfate12$650
Ketoconazole42$607
SsdSilver Sulfadiazine40$463
Minocycline Hcl16$452
Mupirocin25$391
Ciclopirox11$389
Betamethasone Dipropionate14$334
Fluconazole21$321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$14$106,16919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 275 geriatric medicine providers in Texas.

Other geriatric medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →